| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1019821648 |
| P356 | DOI | 10.1038/NATURE02329 |
| P8608 | Fatcat ID | release_4ccfadxoyneb7nx7o5udzgqj6y |
| P3181 | OpenCitations bibliographic resource ID | 1678041 |
| P698 | PubMed publication ID | 15029197 |
| P50 | author | Rakesh Jain | Q7286601 |
| Gene H. Barnett | Q62066084 | ||
| Igor Garkavtsev | Q125211168 | ||
| P2093 | author name string | Frank Winkler | |
| Lei Xu | |||
| Edward Brown | |||
| Sergey V Kozin | |||
| Olga Chernova | |||
| P2860 | cites work | Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells | Q24306649 |
| Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformation | Q24324234 | ||
| Extension of the replicative life span of human diploid fibroblasts by inhibition of the p33ING1 candidate tumor suppressor | Q24646710 | ||
| Angiogenesis in cancer and other diseases | Q27861015 | ||
| Differential association of products of alternative transcripts of the candidate tumor suppressor ING1 with the mSin3/HDAC1 transcriptional corepressor complex | Q28140473 | ||
| The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control | Q28259729 | ||
| Missing pieces in the NF-kappaB puzzle | Q29547864 | ||
| NF-kappaB in cancer: from innocent bystander to major culprit | Q29614603 | ||
| The WHO classification of tumors of the nervous system | Q33845646 | ||
| Clinical translation of angiogenesis inhibitors | Q34152769 | ||
| Malignant glioma: genetics and biology of a grave matter. | Q34272357 | ||
| Genetic and biologic progression in astrocytomas and their relation to angiogenic dysregulation | Q34470458 | ||
| Dissecting tumour pathophysiology using intravital microscopy | Q34632036 | ||
| Upregulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis | Q36380713 | ||
| Role of an ING1 growth regulator in transcriptional activation and targeted histone acetylation by the NuA4 complex. | Q39528848 | ||
| Reduced expression of p33(ING1) and the relationship with p53 expression in human gastric cancer | Q40902101 | ||
| Angiogenesis in malignant gliomas | Q40961541 | ||
| Regulation of interleukin-8 expression by reduced oxygen pressure in human glioblastoma | Q58323583 | ||
| Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1 | Q71644976 | ||
| Suppression of ING1 expression in sporadic breast cancer | Q73023821 | ||
| P433 | issue | 6980 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | brain | Q1073 |
| negative regulation of transcription, DNA-templated | Q14633919 | ||
| Inhibitor of growth family member 4 | Q21107593 | ||
| angiogenesis | Q539568 | ||
| P304 | page(s) | 328-32 | |
| P577 | publication date | 2004-03-18 | |
| P1433 | published in | Nature | Q180445 |
| P1476 | title | The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis | |
| P478 | volume | 428 |
| Q36510818 | 'Pseudopalisading' necrosis in glioblastoma: a familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis |
| Q37588073 | A 22q11.2 amplification in the region encoding microRNA-650 correlates with the epithelial to mesenchymal transition in breast cancer primary cultures of Mexican patients. |
| Q90152154 | A 6-Gene Risk Signature Predicts Survival of Glioblastoma Multiforme |
| Q64075026 | A Multi-Cohort and Multi-Omics Meta-Analysis Framework to Identify Network-Based Gene Signatures |
| Q30557006 | A cranial window imaging method for monitoring vascular growth around chronically implanted micro-ECoG devices |
| Q33940399 | A dominant mutant allele of the ING4 tumor suppressor found in human cancer cells exacerbates MYC-initiated mouse mammary tumorigenesis |
| Q24560000 | A screen for genes that suppress loss of contact inhibition: identification of ING4 as a candidate tumor suppressor gene in human cancer |
| Q24295232 | A splice variant of stress response gene ATF3 counteracts NF-kappaB-dependent anti-apoptosis through inhibiting recruitment of CREB-binding protein/p300 coactivator |
| Q84933381 | Acceleration of clear cell renal cell carcinoma growth in mice following bevacizumab/Avastin treatment: the role of CXCL cytokines |
| Q38757962 | Adenovirus-mediated co-expression of ING4 and PTEN cooperatively enhances their antitumor activity in human hepatocellular carcinoma cells |
| Q39188207 | Adenovirus-mediated expression of BmK CT suppresses growth and invasion of rat C6 glioma cells |
| Q37078019 | An NF-κB p65-cIAP2 link is necessary for mediating resistance to TNF-α induced cell death in gliomas |
| Q39696428 | Angiogenesis and multiple myeloma |
| Q36887534 | Angiogenesis in brain tumours |
| Q45867682 | Antitumoral Cascade-Targeting Ligand for IL-6 Receptor-Mediated Gene Delivery to Glioma |
| Q41145026 | Association between the expression of inhibitor of growth family member 4 and the progression of clear cell renal carcinoma |
| Q89486215 | Autoantibodies against P29ING4 are associated with complex regional pain syndrome |
| Q39150377 | Autophagy contributes to ING4-induced glioma cell death |
| Q37533625 | Biology of angiogenesis and invasion in glioma |
| Q57286577 | C Pyruvate Transport Across the Blood-Brain Barrier in Preclinical Hyperpolarised MRI |
| Q30432791 | CXC chemokines in cancer angiogenesis and metastases |
| Q33614190 | Cancer epigenetics: a brief review |
| Q39634863 | Cell Cycle Regulator ING4 Is a Suppressor of Melanoma Angiogenesis That Is Regulated by the Metastasis Suppressor BRMS1 |
| Q30426904 | Chemokines as mediators of angiogenesis. |
| Q30438032 | Chemokines as mediators of neovascularization |
| Q30427886 | Chemokines as mediators of tumor angiogenesis and neovascularization |
| Q38754218 | Co-expression of ING4 and P53 enhances hypopharyngeal cancer chemosensitivity to cisplatin in vivo |
| Q37045403 | Combinatorial strategies based on CRAd-IL24 and CRAd-ING4 virotherapy with anti-angiogenesis treatment for ovarian cancer |
| Q35615747 | Correlation of IL-8 with induction, progression and metastatic potential of colorectal cancer |
| Q27677284 | Crystal Structure of Inhibitor of Growth 4 (ING4) Dimerization Domain Reveals Functional Organization of ING Family of Chromatin-binding Proteins |
| Q40114999 | Curcumin induces G2/M cell cycle arrest in a p53-dependent manner and upregulates ING4 expression in human glioma |
| Q36637900 | Current insights into the regulation of programmed cell death by NF-kappaB. |
| Q35105219 | Dehydro-alpha-lapachone, a plant product with antivascular activity. |
| Q35011886 | Deletion of the inhibitor of growth 4 (ING4) tumor suppressor gene is prevalent in human epidermal growth factor 2 (HER2)-positive breast cancer |
| Q34660653 | Delivery of inhibitor of growth 4 (ING4) gene significantly inhibits proliferation and invasion and promotes apoptosis of human osteosarcoma cells. |
| Q39975221 | Deregulation of a STAT3-interleukin 8 signaling pathway promotes human glioblastoma cell proliferation and invasiveness. |
| Q55043388 | Detection of novel mRNA splice variants of human ING4 tumor suppressor gene. |
| Q37374032 | Down-regulation of ING4 is associated with initiation and progression of lung cancer |
| Q43153864 | Down-regulation of the inhibitor of growth family member 4 (ING4) in different forms of pulmonary fibrosis. |
| Q84230827 | Downregulated expression of inhibitor of growth 4 (ING4) in advanced colorectal cancers: a non-randomized experimental study |
| Q33833652 | Downregulated inhibitor of growth 3 (ING3) expression during colorectal carcinogenesis |
| Q36099302 | Downregulation of inhibitor of growth 3 is correlated with tumorigenesis and progression of hepatocellular carcinoma |
| Q37010500 | Dual roles of NF-kappaB in cell survival and implications of NF-kappaB inhibitors in neuroprotective therapy |
| Q21198870 | Dysregulation of miR-15a and miR-214 in human pancreatic cancer |
| Q36510801 | EGFRvIII promotes glioma angiogenesis and growth through the NF-κB, interleukin-8 pathway |
| Q36226137 | Effect of the tumor suppressor gene ING4 on the proliferation of MCF-7 human breast cancer cells |
| Q54967270 | Enhanced anti-melanoma efficacy of interferon α-2b via overexpression of ING4 by enhanced Fas/FasL-mediated apoptosis. |
| Q34619830 | Enhanced antitumor activity by combining an adenovirus harboring ING4 with cisplatin for hepatocarcinoma cells |
| Q45881022 | Enhanced radiosensitivity of non-small-cell lung cancer (NSCLC) by adenovirus-mediated ING4 gene therapy |
| Q39527314 | Enhanced tumor suppression by an ING4/IL-24 bicistronic adenovirus-mediated gene cotransfer in human non-small cell lung cancer cells |
| Q39298204 | Exploration of Involved Key Genes and Signaling Diversity in Brain Tumors |
| Q36341464 | Expression and significance of CHIP in canine mammary gland tumors |
| Q41620748 | Expression of ING4 is negatively correlated with cellular proliferation and microvessel density in human glioma |
| Q34488513 | Expression of hypoxia-inducible factor (HIF)-1a-vascular endothelial growth factor (VEGF)-inhibitory growth factor (ING)-4- axis in sarcoidosis patients |
| Q34275711 | Expression of inhibitor of growth 4 by HSV1716 improves oncolytic potency and enhances efficacy |
| Q44753855 | Expression of tumor suppressor gene ING4 in ovarian carcinoma is correlated with microvessel density |
| Q40089440 | Expression profiles of mRNA transcript variants encoding the human inhibitor of growth tumor suppressor gene family in normal and neoplastic tissues |
| Q27664047 | Functional impact of cancer-associated mutations in the tumor suppressor protein ING4 |
| Q37175083 | G-protein coupled chemoattractant receptors and cancer |
| Q34606002 | G-protein-coupled receptors and cancer. |
| Q28291669 | Good cop, bad cop: the different faces of NF-kappaB |
| Q36413775 | Grow-ING, Age-ING and Die-ING: ING proteins link cancer, senescence and apoptosis |
| Q38308716 | HSP70 induction by ING proteins sensitizes cells to tumor necrosis factor alpha receptor-mediated apoptosis |
| Q38746127 | Histone Deacetylase Inhibitor RGFP109 Overcomes Temozolomide Resistance by Blocking NF-κB-Dependent Transcription in Glioblastoma Cell Lines |
| Q39078789 | Histone acetyltransferase Hbo1 destabilizes estrogen receptor α by ubiquitination and modulates proliferation of breast cancers |
| Q52719932 | IL-8 associates with a pro-angiogenic and mesenchymal subtype in glioblastoma. |
| Q42390087 | ING Genes Work as Tumor Suppressor Genes in the Carcinogenesis of Head and Neck Squamous Cell Carcinoma |
| Q33574029 | ING proteins as potential anticancer drug targets |
| Q24300142 | ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation |
| Q24310196 | ING2 as a novel mediator of transforming growth factor-beta-dependent responses in epithelial cells |
| Q24529998 | ING2 regulates the onset of replicative senescence by induction of p300-dependent p53 acetylation |
| Q53132557 | ING3 promotes UV-induced apoptosis via Fas/caspase-8 pathway in melanoma cells. |
| Q27653628 | ING4 Mediates Crosstalk between Histone H3 K4 Trimethylation and H3 Acetylation to Attenuate Cellular Transformation |
| Q35632217 | ING4 enhances paclitaxel's effect on colorectal cancer growth in vitro and in vivo |
| Q45324859 | ING4 expressing oncolytic vaccinia virus promotes anti-tumor efficiency and synergizes with gemcitabine in pancreatic cancer |
| Q24299273 | ING4 induces G2/M cell cycle arrest and enhances the chemosensitivity to DNA-damage agents in HepG2 cells |
| Q24338833 | ING4 inhibits the translation of proto-oncogene MYC by interacting with AUF1 |
| Q44677914 | ING4 is negatively correlated with microvessel density in colon cancer |
| Q37352611 | ING4 regulates JWA in angiogenesis and their prognostic value in melanoma patients |
| Q39162935 | ING4 regulates a secretory phenotype in primary fibroblasts with dual effects on cell proliferation and tumor growth |
| Q61809330 | ING4 suppresses hepatocellular carcinoma via a NF-κB/miR-155/FOXO3a signaling axis |
| Q37694744 | ING4 suppresses tumor angiogenesis and functions as a prognostic marker in human colorectal cancer |
| Q38932782 | INGs are potential drug targets for cancer |
| Q42517415 | Ing1 mediates p53 accumulation and chromatin modification in response to oncogenic stress |
| Q36573962 | Inhibition of tumor growth by NF-kappaB inhibitors |
| Q91386808 | Inhibitor of Growth 4 (ING4) is a positive regulator of rRNA synthesis |
| Q39185512 | Inhibitor of growth 1 (ING1) acts at early steps of multiple DNA repair pathways. |
| Q24675156 | Inhibitor of growth 4 (ING4) is up-regulated by a low K intake and suppresses renal outer medullary K channels (ROMK) by MAPK stimulation |
| Q39159192 | Inhibitor of growth 4 induces NFκB/p65 ubiquitin-dependent degradation |
| Q39912270 | Inhibitor of growth 4 induces apoptosis in human lung adenocarcinoma cell line A549 via Bcl-2 family proteins and mitochondria apoptosis pathway |
| Q36942658 | Inhibitor of growth 4 suppresses cell spreading and cell migration by interacting with a novel binding partner, liprin alpha1. |
| Q47164650 | Inhibitor of growth protein 4 interacts with Beclin 1 and represses autophagy |
| Q37701303 | Inhibitor of growth tumor suppressors in cancer progression |
| Q38709293 | Inhibitor of growth-4 is a potential target for cancer therapy |
| Q37942489 | Inhibitor of growth-4 mediates chromatin modification and has a suppressive effect on tumorigenesis and innate immunity |
| Q33953090 | Inhibitor of growth-4 promotes IkappaB promoter activation to suppress NF-kappaB signaling and innate immunity |
| Q33370422 | Interspecies data mining to predict novel ING-protein interactions in human |
| Q26859017 | Keep-ING balance: tumor suppression by epigenetic regulation |
| Q24648175 | Liposomal honokiol, a potent anti-angiogenesis agent, in combination with radiotherapy produces a synergistic antitumor efficacy without increasing toxicity |
| Q36232178 | Loss of tumor suppressive microRNA-31 enhances TRADD/NF-κB signaling in glioblastoma |
| Q45159575 | Low ING4 protein expression detected by paraffin-section immunohistochemistry is associated with poor prognosis in untreated patients with gastrointestinal stromal tumors |
| Q37209348 | Mechanism of Histone H3K4me3 Recognition by the Plant Homeodomain of Inhibitor of Growth 3. |
| Q36085941 | MicroRNA-650 in a copy number-variable region regulates the production of interleukin 6 in human osteosarcoma cells |
| Q55673135 | MicroRNA-650 targets inhibitor of growth 4 to promote colorectal cancer progression via mitogen activated protein kinase signaling. |
| Q52816041 | Modification of degradable nonviral delivery vehicle with a novel bifunctional peptide to enhance transfection in vivo. |
| Q38644746 | Modulation of NF-κB Signaling as a Therapeutic Target in Autoimmunity. |
| Q87353759 | Molecular cloning and expression analysis of inhibitor of growth protein 3 (ING3) in the Manila clam, Ruditapes philippinarum |
| Q58779206 | NF-κB, Mesenchymal Differentiation and Glioblastoma |
| Q34442193 | Negative regulation of NF-κB by the ING4 tumor suppressor in breast cancer |
| Q80244920 | Neuro-oncology in a nutshell |
| Q34566192 | Novel splice variants of ING4 and their possible roles in the regulation of cell growth and motility |
| Q29547879 | Nuclear factor-kappaB in cancer development and progression |
| Q36085634 | Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs |
| Q38624686 | Nuclear factor-κB in glioblastoma: insights into regulators and targeted therapy |
| Q36561651 | Oncogenic Ras suppresses ING4-TDG-Fas axis to promote apoptosis resistance. |
| Q38759685 | Overexpression of Inhibitor of Growth 4 Enhances Radiosensitivity in Non-Small Cell Lung Cancer Cell Line SPC-A1. |
| Q36230509 | Patient outcome prediction using multiple biomarkers in human melanoma: A clinicopathological study of 118 cases |
| Q34346845 | Phylogenetic analysis of the ING family of PHD finger proteins |
| Q40147252 | Prospero-related homeobox 1 drives angiogenesis of hepatocellular carcinoma through selectively activating IL-8 expression |
| Q57293808 | Proteomic analysis of the OGT interactome: novel links to epithelial-mesenchymal transition and metastasis of cervical cancer |
| Q34939141 | Radiation sensitization of glioblastoma by cilengitide has unanticipated schedule-dependency |
| Q34100927 | Reduced ING1 levels in breast cancer promotes metastasis |
| Q37374077 | Reduced expression and novel splice variants of ING4 in human gastric adenocarcinoma |
| Q36741969 | Reduced expression and prognostic implication of inhibitor of growth 4 in human osteosarcoma |
| Q38085060 | RegulatING chromatin regulators: post-translational modification of the ING family of epigenetic regulators. |
| Q37957713 | Regulation of p53 by ING family members in suppression of tumor initiation and progression |
| Q37464700 | Reviewing the current classification of inhibitor of growth family proteins. |
| Q42727110 | Role of CXCR2/CXCR2 ligands in vascular remodeling during bronchiolitis obliterans syndrome |
| Q39997072 | Role of ING4 in human melanoma cell migration, invasion and patient survival |
| Q28290234 | Roles for NF-kappaB in nerve cell survival, plasticity, and disease |
| Q35228761 | SCF(JFK) is a bona fide E3 ligase for ING4 and a potent promoter of the angiogenesis and metastasis of breast cancer |
| Q37550760 | STAT3 regulation of glioblastoma pathogenesis. |
| Q52590872 | Sirtuin 7 Deficiency Ameliorates Cisplatin-induced Acute Kidney Injury Through Regulation of the Inflammatory Response. |
| Q92099340 | Small GTPase RHOE/RND3, a new critical regulator of NF-κB signalling in glioblastoma multiforme? |
| Q40297096 | Subcellular targeting of p33ING1b by phosphorylation-dependent 14-3-3 binding regulates p21WAF1 expression |
| Q38847744 | Synergistic action of 5Z-7-oxozeaenol and bortezomib in inducing apoptosis of Burkitt lymphoma cell line Daudi |
| Q58565390 | Synergistic suppression effect on tumor growth of acute myeloid leukemia by combining cytarabine with an engineered oncolytic vaccinia virus |
| Q38819732 | Synergistic tumor suppression by adenovirus-mediated ING4/PTEN double gene therapy for gastric cancer |
| Q47368390 | Targeted disruption of the mouse ing1 locus results in reduced body size, hypersensitivity to radiation and elevated incidence of lymphomas |
| Q58766247 | The Diverse Roles of microRNAs at the Host⁻Virus Interface |
| Q37783946 | The ING family tumor suppressors: from structure to function |
| Q33858272 | The ING gene family in the regulation of cell growth and tumorigenesis |
| Q34964035 | The ING4 Binding with p53 and Induced p53 Acetylation were Attenuated by Human Papillomavirus 16 E6. |
| Q36949738 | The ING4 tumor suppressor attenuates NF-kappaB activity at the promoters of target genes |
| Q34410314 | The MOZ histone acetyltransferase in epigenetic signaling and disease. |
| Q36908407 | The MYST family of histone acetyltransferases and their intimate links to cancer. |
| Q26748938 | The Ubiquitination of NF-κB Subunits in the Control of Transcription |
| Q39634060 | The altered expression of ING5 protein is involved in gastric carcinogenesis and subsequent progression |
| Q92841028 | The association of inhibitor of Growth 4 with its prognostic value in osteogenic sarcoma |
| Q24529065 | The candidate tumor suppressor ING4 represses activation of the hypoxia inducible factor (HIF). |
| Q61805827 | The essential role of tumor suppressor gene in various human cancers and non-neoplastic disorders |
| Q39182611 | The hypoxia target adrenomedullin is aberrantly expressed in multiple myeloma and promotes angiogenesis. |
| Q47813995 | The nuclear factor-kappa B pathway and response to treatment in breast cancer |
| Q39814307 | The prolyl isomerase Pin1 regulates the NF-kappaB signaling pathway and interleukin-8 expression in glioblastoma |
| Q34411509 | The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis |
| Q57580223 | The tumor suppressor ING1 contributes to epigenetic control of cellular senescence |
| Q28071572 | Therapeutic Potential of Curcumin for the Treatment of Brain Tumors |
| Q37324729 | Time-lapse imaging of disease progression in deep brain areas using fluorescence microendoscopy |
| Q34926660 | Trichothecin induces cell death in NF-κB constitutively activated human cancer cells via inhibition of IKKβ phosphorylation |
| Q39093050 | Tumor suppressor ING4 overexpression contributes to proliferation and invasion inhibition in gastric carcinoma by suppressing the NF-κB signaling pathway |
| Q39921861 | Tumor suppressor SMAR1 represses IkappaBalpha expression and inhibits p65 transactivation through matrix attachment regions |
| Q33757944 | Tumor vasculature is regulated by PHD2-mediated angiogenesis and bone marrow-derived cell recruitment |
| Q35545371 | Two-photon fluorescence vascular bioimaging with new bioconjugate probes selective toward the vascular endothelial growth factor receptor 2. |
| Q26998535 | Ubiquitin-mediated NFκB degradation pathway |
| Q47413951 | Upregulation of miR-650 is correlated with down-regulation of ING4 and progression of hepatocellular carcinoma |
| Q53064422 | [The mechanism of inhibition effect of adenovirus-mediated ING4 on human lung adenocarcinoma xenografts in nude mice]. |
| Q38099450 | iNOS: a potential therapeutic target for malignant glioma |
| Q48597370 | miR-423-5p contributes to a malignant phenotype and temozolomide chemoresistance in glioblastomas |
Search more.